SynCardia Selected as a Finalist for the 2012 MEDTEC Europe Innovation Awards

Tucson, Ariz. (PRWEB) January 26, 2012
SynCardia Systems, Inc., manufacturer of the worlds first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that it has been nominated for one of the most prestigious awards in the European medical device industry.
The Freedom? portable driver, the worlds first wearable power supply for the SynCardia temporary Total Artificial Heart, has been shortlisted for Most Innovative Cardiac Product of the Year as part of the MEDTEC European Medical Device Technology (EMDT) Innovation Awards. The Awards are the only European awards dedicated to recognizing achievements in the medical device sector.
These awards are regarded as a universal benchmark of quality within the medical-device industry, said Michael Garippa, SynCardia CEO/President. Being shortlisted is a tremendous achievement. The Freedom portable driver has been pivotal in the Total Artificial Heart becoming the new standard of care for end-stage biventricular heart failure.
Weighing approximately 6 kg (13.5 lbs), the Freedom portable driver allows stable Total Artificial Heart patients to be discharged from the hospital to enjoy life at home while they wait for a matching donor heart. The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S. More than 70 patients worldwide have been supported by the Freedom driver, accounting for more than 24 years of patient support.
This years winners will be announced on March 14, 2012, at a special ceremony during MEDTEC Europe 2012, in the Atrium of the Messe Stuttgart in Stuttgart, Germany.
About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world’s first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, SynCardia’s Total Artificial Heart is currently approved as a bridge to transplant for people dying from end-stage biventricular heart failure. There have been more than 950 implants of the Total Artificial Heart, accounting for more than 230 patient years of life.
Similar to a heart transplant, SynCardia’s Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers and does not require expensive anti-rejection medication, which can cause subsequent complications. It is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through both ventricles. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.
SynCardia Ranked #20 Among World’s 50 Most Innovative Companies
In March 2011, Fast Company magazine ranked SynCardia #20 in its annual list of the “World’s 50 Most Innovative Companies” for “giving mobility to artificial heart recipients.” Weighing 13.5 pounds, SynCardia’s Freedom? portable driver is the world’s first wearable driver designed to power the Total Artificial Heart both inside and outside the hospital. The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.
Like SynCardia on Facebook
Follow SynCardia on Twitter @SynCardia
###
Find More European Press Releases
BRIC Countries Make Up Major Driver of Butadiene Demand Growth According to Merchant Research & Consulting Ltd

London, UK (PRWEB) January 12, 2012
The demand on the global butadiene market is indicating reasonable growth it is also expected that it will move upwards by 2-2,5% annually in the coming 5-6 years. The butadiene markets in the developed countries are not considered as considerable contributors to the demand growth the market has already reached its saturation point. However the developing BRIC countries make up the major driver behind the butadiene industry activity.
Up to 50% of the produced volume of butadiene is taken up by SBR and polybutadiene. These applications are forecast to lead the demand in the near future as they are both set to lavishly develop through 2017.
Insightful information and analysis of the butadiene market is the focus of the new market research report Butadiene (BD): 2012 World Market Outlook and Forecast up to 2017. The report provides a close-up review of the global, regional and country-wise markets for butadiene. The analysis offered by the study incorporates data on the past and present market situation and unveils detailed market projections.
The butadiene industry is examined in detail and the key market parameters are indicated – production and consumption in the reviewed countries, trade activities, prices for the material in the reviewed periods. Market projections present the future of butadiene industry in the coming 5 years and show the future trends and opportunities, volumes and prices.
Report Details:
Butadiene (BD): 2012 World Market Outlook and Forecast up to 2017
Published: January, 2012
Pages: 102
http://mcgroup.co.uk/researches/butadiene-bd
Report Contents:
DISCLAIMER
RESEARCH METHODOLOGY
1. INTRODUCTION: BUTADIENE PROPERTIES AND USES
2. BUTADIENE MANUFACTURING PROCESSES
3. BUTADIENE WORLD MARKET
3.1. World Butadiene capacity
????Butadiene capacity broken down by region (incl. regions shares)
Butadiene capacity divided by country (incl. countries shares)
Butadiene producers and their capacity (by plant)
3.2. World Butadiene production
Butadiene global output dynamics (2003-present)
Butadiene production by region
Butadiene production by country
3.3. Butadiene consumption
World consumption of Butadiene (2003-present)
Butadiene consumption by end use sector, 2010
Butadiene consumption trends in Europe (incl. historical background 2003-2011)
Butadiene consumption trends in Asia (incl. historical background 2003-2011)
Butadiene consumption trends in North America (incl. historical background 2003-2011)
3.4. Butadiene global trade
World Butadiene trade dynamics
Butadiene export and import flows in regions
3.5. Butadiene prices in the world market
4. BUTADIENE EUROPEAN MARKET ANALYSIS
Total Butadiene capacity in Europe by country (with shares)
Butadiene production in Europe by country
Butadiene manufacturers in Europe
Top Butadiene manufacturers and their shares in European market
Consumption of Butadiene in Europe
Butadiene suppliers in Europe
Butadiene export and import in Europe
Butadiene prices in Europe
5. BUTADIENE ASIAN MARKET ANALYSIS
Total Butadiene capacity in Asia by country (with shares)
Butadiene production in Asia by country
Butadiene manufacturers in Asia
Top Butadiene manufacturers and their shares in Asian market
Consumption of Butadiene in Asia
Butadiene suppliers in Asia
Butadiene export and import in Asia
Butadiene prices in Asia
6. BUTADIENE NORTH AMERICAN MARKET ANALYSIS
Total Butadiene capacity in North America by country (with shares)
Butadiene production in North America by country
Butadiene manufacturers in North America
Top Butadiene manufacturers and their shares in North American market
Consumption of Butadiene in North America
Butadiene suppliers in North America
Butadiene export and import in North America
Butadiene prices in North America
7. BUTADIENE LATIN AMERICAN MARKET ANALYSIS
Total Butadiene capacity in Latin America by country (with shares)
Butadiene production in Latin America by country
Butadiene manufacturers in Latin America
Top Butadiene manufacturers and their shares in Latin American market
Consumption of Butadiene in Latin America
Butadiene suppliers in Latin America
Butadiene export and import in Latin America
Butadiene prices in Latin America
8. BUTADIENE AFRICA AND MIDDLE EAST MARKET ANALYSIS
Total Butadiene capacity in Africa and Middle East by country (with shares)
Butadiene production in Africa and Middle East by country
Butadiene manufacturers in Africa and Middle East
Top Butadiene manufacturers and their shares in Africa and Middle East market
Butadiene suppliers in Africa and Middle East
Butadiene export and import in Africa and Middle East
Butadiene prices in Africa and Middle East
9. BUTADIENE OCEANIA EAST MARKET ANALYSIS
Total Butadiene capacity in Oceania by country (with shares)
Butadiene production in Oceania by country
Butadiene manufacturers in Oceania
Butadiene suppliers in Oceania
Butadiene prices in Oceania
10. BUTADIENE MARKET PERSPECTIVES
10.1. Butadiene capacity and production forecast up to 2017
Butadiene global supply forecast
????10.1.1. Butadiene projects
???? – New Butadiene capacity introductions
10.2. Butadiene consumption forecast up to 2017
Future trends in Butadiene market worldwide
Butadiene world consumption forecast
Butadiene consumption forecast in Europe
Butadiene consumption forecast in Asia
Butadiene consumption forecast in North America
10.3. Estimated Butadiene prices changes up to 2017
Butadiene prices forecast in Europe
Butadiene prices forecast in Asia
Butadiene prices forecast in North America
11. KEY COMPANIES IN THE BUTADIENE MARKET WORLDWIDE
TPC Group Inc
???? TPC Group Inc overview
???? TPC Group Inc’s butadiene business
???? TPC Group Inc’s place in world butadiene market
LyondellBasell
???? LyondellBasell overview
???? LyondellBasell ‘s butadiene business
???? LyondellBasell ‘s place in world butadiene market
Shell
???? Shell overview
???? Shell’s butadiene business
???? Shell’s place in world butadiene market
Sabic Corp
???? Sabic Corp overview
???? Sabic Corp’s butadiene business
???? Sabic Corp’s place in world butadiene market
Formosa Petrochemical Corp – (FPCC)
???? Formosa Petrochemical Corp overview
???? Formosa Petrochemical Corp’s butadiene business
???? Formosa Petrochemical Corp’s place in world butadiene market
12. FEEDSTOCK MARKET
Butadiene feedstocks capacity worldwide
Trends in Butadiene feedstocks markets globally
Prices for Butadiene feedstocks in world market
Butadiene feedstocks markets perspectives
LIST OF TABLES
LIST OF FIGURES
Monthly report updates for Butadiene (BD): 2012 World Market Outlook and Forecast up to 2017 are also available.
The report on butadiene has been provided by Merchant Research & Consulting Ltd, an internationally recognized market research agency, specializing in chemical industry. Butadiene (BD): 2012 World Market Outlook and Forecast up to 2017 is covered within the cata
Related European Press Releases
Gnosis Introduces – Joy of Life – a Limited Edition of $150K Stone Mosaics
Atlanta, GA (PRWEB) December 30, 2011
Atlanta-based Gnosis, maker of usance mosaic, will food an express printing of 10 rock mosaic, handmade with some of the finest stone stuff. The express offering terms of $ 150,000 each will spring 10 owner the chance to familiarisation a historic art industry antialiasing that date dorsum to Ancient Rome.
In a paw-crafting antialiasing passed feather maiden the century, the mosaic are shaped with cock and block and then mounted on textile cloth. In this unique procedure, the shaper contour each part of rock, single by I, to food the designing.
The featured designing will be Gnosiss Sousse shape, a designing that is legendary in the yesteryear of mosaic. This art was former made in North Africa in the play of Roman domination in the 3rd Century AD, and it was the former rock art that ever integrated inkiness infinite. This contrast with the typical aid of African floral mosaic of the Saame play in which the form are merely outlined on a Caucasian heritage.
The suggested circumference of the art will be 6 foot by 12 ft, but emptor will have the derivative of modifying the circumference as desired. The mosaic tin be installed on floor, on wall, or simply framed in site iron and showcased as a portion of creation.
The express printing rock mosaic will characteristic mulct French and Italian rock material, including Bianco Paonazo, Rouge Langedoc, Bardiglio Imperiale, and Giallo Sienna among others. All of the stone will be manus-selected in France and Italy.
We are very excited about these express impression mosaic. They will be the finest mosaic we have produced to maturity, said Sandra Ghaoui, President of Gnosis. This is thing I always wanted to do because it combine everything I adoration about mosaic: the stuff, the antialiasing, the designing and the yesteryear.
Wondering what you return for $ 150,000?
The mosaic will seed with European authorities-issued credentials attesting that the stone used is the highest appearance. These certification will semen in repository-form formulation. Unless otherwise specified, the mosaic will be mounted on an usance stainless alloy framework, guaranteed for century years. Owners will also be presumption a tetrad-tomorrow, all-paid former-world flight for deuce to Timgad, Algeria, where they will have the chance to perspective and appreciate the master Sousse art designing made 1,800 twelvemonth ago. Buyers will also be precondition II copy of hard-boundary book with fabric cover, which will provide detailed description of how the art was produced, including the option of the rock, the designing cultivation, the manus-crafting procedure, and the practice of the antialiasing used. These book will be dedicated in an offer impression printed exclusively for the proprietor.
I expectancy to stock with the proprietor my passionateness for art creation, pickings them on a memorable journeying through the cosmos and yore of art creation, and spring them a portion that will be impregnated with memory Ghaoui said. I expectancy that every clip they seat their art, they remember their familiarisation.
The Agricola populace will be able to follow the porno of these chef-d’oeuvre through the Gnosis -Custom Mosaics- establishment site, where update, interview and video will be posted regularly.
About Gnosis Custom Mosaics
Founded in 2004, Atlanta-established Gnosis, http://www.gnosis-mosaics.com, crafts customised-designed, hand-made mosaics by merging antediluvian crafting traditions with modern-day designing. Whether client start specifying a mosaic drawing from Gnosis extensive catalog of designing or commission an entirely new porno, Gnosis custom make its mosaic to each client selection of colour, criterion and geometry. In addition to the firms served for high-profile residences and indulgence infomercial developments, Gnosis has partnered with established architectural and interior designing firms, including Design Galleria Kitchen &A; Bath Studio, Harrison Design Associates, Suzanne Kasler Interiors and Grupo Diarq.
Connect with us on Facebook and Twitter
###
Germanys Refusal to a Permanent Rise in the Stabilization Fund Leads to a Sharp Fall in European and US Markets Reports ITFX

(PRWEB) December 16, 2011
Though the marketplace experienced film sentimentality earlier in the tomorrow with the Spanish authorities marketing bond halfpennyworth 4.94 1000000000000 Euros or 6.51 1000000000000 Dollars at relatively depression output of LE than 5 pct, report indicating that Germany had opposed a perm outgrowth in the stabilisation money resulted in capital trading in the European market departure into a downward curve. Experts at the Forex money conversation institution InvestTechFX study that the recognition evaluation of statesman bank in the Euro Zone state were on the formation with the emerging liability Dunkirk on the Africa screening no sign of abating. Despite the vendue of these bond, the recognition valuation of octonary of Spains financial establishment and bank are also expected to return harm per Fitchs and Moodys warnings.
Norbert Lammert, interpreter for the German legislative stated that expecting Germany to approve the improvement money was quite an ambitious outlook. Forex investor are a troubled slew as there is no comp foreseeable brine to avoid futurity indebtedness crisis on the Africa. With evaluation bureau continuing to place the sentimentality on the Africa, warnings regarding the recognition valuation of as many as 17 company in the Euro Zone were also issued. These include the EFSF (EU deliverance money) and the bank on the earth. Stocks market in the US also experienced a sharp autumn after economist at Moody announced that the Euro Zone would familiarisation further and significant economic lag disdain dialogue and measure taken to revive the industrialism of country sort Greece that is 350 1000000000000 Euros in indebtedness.
The online Forex Trading establishment InvestTechFX is a proven somebody in the manufacture of artificial brainpower package. They are renowned for their cap incisura trading engineering scheme in the computerized trading manufacture whose expert develop advanced, customizable, intuitive, efficient, and sophisticated trading tool that assist peoples understand Forex trading related tendency and development. Apart from offer new, exciting, and innovative FX trading solutions, they are excavation known for their detailed and comp acquisition middle.
http://www.youtube.com/watch?characteristic=player_embedded&ere;v=ffysJqNNUl4
###
Released by Discover Enterprise – Street Fighting Professor Comes Out Swinging to Beat the Recession
Belfast, UK (PRWEB) December 04, 2011
Hes big, hes mean and a street fighting machine!
Well maybe not in the traditional sense as nowadays Professor David Gibsons biggest punch comes in the form of guiding others in how to succeed through honing their enterprise success skills. Although, make no mistake, with his powerful frame and dogged determination this former terror of the Rugby field is not to be trifled with. Hes already built a reputation in the world of business and education that is second to none. In fact he recently won the ultimate accolade of No. 1 Enterprise Educator in the World, bestowed on him by the United States Association of Small Business and Entrepreneurship. Not bad for the former Accountant who went from owning a high flying accountancy practice to being practically down and out with despair due to hating his occupation and then bouncing, back up to his current status as the best Enterprise Educator in the world.
If theres one thing in this world I really understand and care about its enterprise. Its helping others to succeed and become the best at what they do. If I can help others succeed then I know I am fulfilling my lifes destiny because that is what I was put on this earth to do. I have been at the bottom of the abyss before and used my street fighting enterprise skills to get back up again. Now its time to help others achieve their lifes ambitions. Lets beat this recession together states Professor Gibson.
“Having Enterprise skills helps people to be much more versatile in their everyday lives. It enables them to problem solve much more effectively and to be able to create and implement new ideas and new ways of doing things. It encourages a ‘can do’ attitude and the drive to make ideas happen while raising their aspirations to achieve greater things by instilling confidence in their overall ability. Being enterprising is not necessarily about making millions of dollars; instead it is about having the motivation and the know-how to turn ideas and opportunities into realities.
Professor Gibson is currently releasing copies of his e book, The Enterprise Success Secret. This is a short fictional tale which is guaranteed to inspire those who read it. Aimed at those people who want to make changes in their lives this book is a solid first step towards their new life. As Professor Gibson readily admits hes been in the abyss and fought his way out. Now in this poor economic climate he wants to help others do the same.
In the spirit of Christmas he is making his e book available at a very low cost (US$ 9.95) and with the ability to send it as a Christmas gift. Purchase one copy and you can then opt to send it through Professor Gibsons website as a gift to up to ten other people. These people can then register for a competition as Professor Gibson will be choosing a lucky winner whom he will lead by the hand through a full eight weeks personal enterprise coaching package. Everyone else who enters will be able to make use of a free eight week internet based course designed to hone their enterprise skills to perfection. Some of the proceeds from the book sales will also be donated to the lucky winner to enable them to make the changes in their life or business that they wish. Contact http://www.enterprisesuccesssecret.com to find out more about the book, the competition and how to Street fight your way to success in the next twelve months.
Professor David Gibson is a senior teaching fellow at the Queens University Belfast Management School. His prestigious awards recognise him as “a trail-blazer” for entrepreneurial education. Among his achievements is developing an enterprise for life education model which is embedded across the entire curriculum at Queen’s University. It has also been adopted by universities in China, India, Canada, Sri Lanka and throughout the UK and is recognised as a best practice model by the European Community. He is a much sought after consultant and speaker.
If you’d like more information about this topic, or to schedule an interview with Professor Gibson, please contact Jeff Thomas at hello @ enterprisesuccesssecret.com
###
Related European Press Releases
Multiple SPC Applications Identified for Vildagliptin Products
(PRWEB) December 05, 2011
The article by GenericsWeb highlights the following observations in relation to generic Vildagliptin:
????Galvus and Eucreas are currently available as oral tablet formulations.
????Vildagliptin is currently authorised in Europe and Australia, however Vildagliptin is not currently approved in Canada or the US.
????The earliest patent family identified as relating to Vildagliptin relates to the use of DPP-4 inhibitors for the treatment of diseases which are based on glucose concentrations, a group amongst which Vildagliptin is included. Opposition proceedings were brought against the granted European patent within this family by Boehringer Ingelheim, Bristol-Myers Squibb, Glaxo, Novartis, Novo Nordisk, Takeda, Tanabe Seiyaku and Pfizer, resulting in revocation of the patent.
????Novartis molecule patent family protection for Vildagliptin remains in force in all major territories until December 2019. In Europe, Supplementary Protection Certificates (SPCs) and a national patent term extension in Australia extend the Vildagliptin molecule protection until September 2022 and December 2024 respectively.
????Additional SPC applications within the molecule patent family have also been filed for the fixed dose combination of Vildagliptin with Metformin. These will provide nearly two months additional protection until November 2022 if granted, however such SPC applications have been rejected in certain European states.
????A later filed patent family with expiries of January 2021 claims antidiabetic combinations, specifically Vildagliptin in combination with Metformin, and as such is considered to be constraining for marketed products containing this fixed combination. Again, SPCs have been filed for this combination with expiries of November 2022 if granted.
????In all major territories where Vildagliptin has been marketed, the data and marketing exclusivity do not extend beyond patent protection.
????Competing innovator companies with interest in DPP-4 inhibitors appear in the top applicants for patents that can be related to Vildagliptin, including Boehringer Ingelheim (Linagliptin), Bristol-Myers Squibb (Saxagliptin), Takeda (Alogliptin) and GlaxoSmithKline due to cross over of claimed inventions into other, similar products.
????Since approval, there has been consistent filing of patent applications in the area of combination, use and analytical method (assay) patents relating to Vildagliptin.
GenericsWeb notes that: In summary, protection remains in force for the Vildagliptin molecule as a result of specific molecule patents which represent a barrier to generic competition to Galvus?. Furthermore, generic combinations of Vildagliptin and Metformin are also protected for an additional period of less than two months due to subsequent filing of SPCs. However the protection varies significantly across countries even in the EU, where patent protection is sought to be harmonised. Due to the complex patent landscape surrounding Vildagliptin, it is likely that the launch date of Vildagliptin generic products will vary significantly in individual countries. Subsequent protection of molecular forms, processes and formulations for this molecule appear to be relatively weak, thus when generic entry is possible, it is likely that it will be heavily competed.
The prominence and continuing growth of the global diabetes pharmaceutical industry means that even at this relatively early stage generic companies will closely watch the patent landscape surrounding Vildagliptin and any future developments in its lifecycle.
You can read the entire article here at: http://www.genericsweb.com/druginfocus/Vildagliptin
ABOUT GENERICSWEB THE SEARCH IS OVER
GenericsWeb, the leader in pharmaceutical patent analysis and searching holds an impeccable track record in providing quality patent information, and has allowed numerous pharmaceutical companies to successfully navigate intellectual property hazards. GenericsWeb is headquartered in Sydney, Australia, with offices in North America and Europe. All staff are highly skilled and experienced internationally and have extensive experience in pharmaceutical sciences and patent searching. For more information, visit the company’s web site at http://www.genericsweb.com.
###
Find More European Press Releases